Helen McBride

Helen McBride is an accomplished professional in the life sciences sector with a strong background in research and development. Holding a Ph.D. in Oncological Sciences from the University of Utah and a post-doctoral degree in Developmental Neurobiology and Biology from Caltech, Helen has held several key positions including Operating Partner at BOLD Capital Partners, Advisor at DNATWO, Independent Board Member at Karma Biotechnologies, and Senior Vice President of Translational Sciences at TORL BioTherapeutics, LLC. Additionally, Helen served as Managing Director for the Fund@Caltech and as an Entrepreneur In Residence at Caltech, demonstrating a deep commitment to advancing biotechnological innovation and collaboration in the industry.